Advanced Therapies Europe 2026 for Tools, Tech & Solution Providers

Tools, Tech & Solution Providers

Reach the European biotechs ready to buy

Advanced Therapies Europe is where Europe's most active biotech and pharma decision-makers come to evaluate the partners, platforms, and providers shaping their next stage of growth.

If you're scaling into Europe, or expanding your footprint within it — ATE puts you in a curated room of buyers, not browsers. Every conversation is with someone actively making decisions about tools, technology, and infrastructure.

✅ 996 pre-arranged meetings in 2025.
✅ 600 senior decision-makers across the European CGT ecosystem.
✅ Curated meeting concierge to match you with the right accounts.

A strictly curated audience of 600 ensures you meet decision-makers, not just attendees.

Apply to attend

Selling into Europe's CGT market

Europe's advanced therapies market is shifting fast. The focus has moved from early science to commercial execution — and the biotech and pharma companies driving it are under more pressure than ever to scale, prove value, and execute. That changes what they need from their tools, technology, and service partners.

European biotechs are increasingly run by commercially-minded leadership making faster, more informed buying decisions about the partners and platforms they bring in
Decision-makers in early-stage biotechs are harder to locate and harder to reach through standard outbound channels
The fragmented European market means navigating different regulatory and operational realities across countries, and clients want vendors who understand that complexity

This is where ATE becomes commercially critical:

Meet the buyers who matter

Connect with biotech and pharma leaders actively evaluating tools, technology, and services for their next stage of growth — in a curated room, not a crowded one.

Build pipeline that converts

Have meaningful conversations with decision-makers at clinical-stage and scaling biotechs, pharma teams, and CDMOs — the buyers shaping spending decisions across Europe.

Reach decision-makers you can't find elsewhere

Get face-to-face with senior biotech leaders who are typically hard to reach through standard outbound. A curated room means the right buyers are already in front of you.

Move faster with the right conversations already in place

996 pre-arranged, concierge-led meetings ensure your time is spent advancing deals, not chasing leads.

Key Agenda Themes in 2026

The operational and commercial realities of CGT - Sessions on the real-world pressures your clients are working through, including AAV manufacturing, CMC cost of goods, and what scaling cell and gene therapy actually takes.
Where biotech buying decisions are heading - Discussions on what determines commercial success, the economics of CMC, and where process and platform choices change the cost picture, all topics shaping the next wave of vendor conversations.
Building partnerships that last - Engage decision-makers in structured meetings designed for outcomes. A curated audience ensures conversations are relevant, focused and commercially aligned.

Automation and decentralised manufacturing - Dedicated Special Interest Groups bringing the industry together on the operational shifts shaping how cell and gene therapies will be produced.
Designing CGTs in the age of agentic AI - A plenary on how AI is reshaping the way therapies are discovered, developed and brought to market, the wider industry shift that frames where vendor solutions need to go next.

View the Agenda

Built for Vendors Selling into Europe

If you’re preparing for your next funding round, strategic partnership, or commercial milestone, this is where those conversations move forward. Designed for clinical-stage and scaling biotechs, Advanced Therapies Europe gives you direct access to the capital, partners, and insight needed to move from progress to execution.

If you’re evaluating where to spend your time and budget this year, this gives you a clear view of the return.

The Delegate Pack shows you who’s in the room, what conversations are happening, and how to make your time count, before you decide to attend.

Inside the delegate pack:

A breakdown of attending biotechs, pharma, CDMOs and investors
Insight into the partnerships and conversations happening across the room
How the 1:1 meeting concierge works and how you’re matched
An overview of the agenda, themes, and key discussion area

Download the Delegate Pack

Who you'll meet at ATE 2026

2025 Attendee List 2025 Exhibitor List

600

CGT Leaders

40+

Countries

100000000

EUR Capital Represented

1000+

1:1 Partner Meetings

"What an incredible few days at the ATE conference by Phacilitate! Grateful for the power of my network and the opportunity to meet so many familiar faces while growing it further.”

Head of Business Development: Cell Therapy and Laboratory Services | Cell and Gene Therapy
“Impactful moments and connections.”

Director Global Cell and Gene Therapies Portfolio Management | EMBA | Deep Tech
“Already having fantastic conversations here at ATE24 in Lisbon.”

Experienced Leader in Cell and Gene Therapy Business and Commercial Strategy